News Conference News ACC 2025 More ALIGN-AR Data Bolster Potential for a Dedicated AR Device Yael L. Maxwell March 30, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Conference News ACC 2023 Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better Shelley Wood March 10, 2023
News Conference News ACC 2023 TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR Todd Neale March 04, 2023
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Conference News ACC 2022 Leaks After LAA Occlusion Tied to Uptick in Thromboembolic Events Todd Neale April 04, 2022
News Conference News ACC 2021 Low 1-Year Stroke Risk After Commercial Watchman Use Todd Neale May 15, 2021
News Conference News ACC 2021 Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III Todd Neale May 15, 2021
News Conference News ACC 2020 LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout Todd Neale April 06, 2020
News Conference News ACC 2019 My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay Shelley Wood April 05, 2019
News Conference News ACC 2019 TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients Yael L. Maxwell March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News ACC 2018 NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients Shelley Wood March 10, 2018
News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017
News Conference News ACC 2017 Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit Todd Neale March 19, 2017
News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012